Aytu Biopharma, Inc. · NASDAQ:AYTU
Kanen Wealth Management LLC reported a 6.40% stake in Aytu Biopharma, Inc. (Schedule 13G)
Event Jun 6, 2025 · Filed Jun 26, 2025
Kanen Wealth Management LLC reported a 6.40% stake in Aytu Biopharma, Inc., 573,358 shares, as a passive investor on Jun 6, 2025. Filed Jun 26, 2025 (Schedule 13G).
- Stake
- 6.40%
- Shares
- 573,358
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Philotimo Fund, LP | 4.30% | 384,150 |
| Philotimo Focused Growth & Income Fund | 2.10% | 189,208 |
| Kanen Wealth Management LLC | 6.40% | 573,358 |
| Kanen David | 6.40% | 573,358 |
Source
Related
- Aytu Biopharma, Inc.
- Kanen Wealth Management LLC
- Aytu Biopharma, Inc. shareholders
- Schedule 13G/A · Kanen Wealth Management LLC · Nov 12, 2025
- Schedule 13G · Kanen Wealth Management LLC · Jun 26, 2025
- Schedule 13G/A · Kanen Wealth Management LLC · Jun 26, 2025
- Schedule 13G/A · Kanen Wealth Management LLC · Jun 26, 2025
- Schedule 13G/A · Laurence W. Lytton · Aug 14, 2026
- Form 4 · Jain Abhinav · Jul 30, 2026
- Form 4 · Dockery Carl · Jul 30, 2026
- Form 4 · Liu Vivian H · Jul 30, 2026
- Form 4 · Disbrow Joshua R. · Jul 30, 2026